Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Autologous Transplantation

Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis

Bone Marrow Transplantation volume 29, pages 473–477 (2002)Cite this article

Abstract

The aim of our study was to evaluate the impact of an early intensification programme including chemotherapy (CHT), autologous stem cell transplantation (ASCT) and radiation therapy (RT) in patients with primary mediastinal large B cell lymphoma (MLCL) with sclerosis presenting with adverse prognostic factors. Between 1993 and 1999, 19 patients with MLCL were referred to our institution. Four patients were classified as low risk according to the age-adjusted International Prognostic Index (AA-IPI). Fifteen (79%) were categorised in the high–intermediate or high risk group and were considered eligible for ASCT. Induction therapy consisted of VACOP-B (etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone and bleomycin) for 12 weeks. After induction therapy the four low risk patients achieved a complete remission (CR) and did not undergo ASCT. Of the 15 poor risk patients, five achieved CR, seven partial remission (PR), and three showed refractory disease (RD). All these patients received mobilising therapy consisting of high-dose cyclophosphamide. After peripheral stem cell (PSC) collection, to obtain a greater tumor mass reduction before transplantation, the seven patients in PR underwent further treatment with high-dose etoposide and those with RD received two cycles of DHAP (dexamethasone, cytarabine and cisplatin). At the time of ASCT, seven patients were in CR, six in PR and two had RD. After transplantation using BEAM as preparative regimen, all patients but one achieved a CR. Seven patients with minimal (<25%) residual mass at computed tomography scan received further mediastinal RT even if they had a negative Ga67 scan. At a median follow-up of 35 months from transplantation the disease free survival is 93%. The outcome following this programme of early intensification in poor prognosis MLCL results in a high incidence of durable remissions even in patients with refractory disease.

Bone Marrow Transplantation (2002) 29, 473–477. doi:10.1038/sj.bmt.1703401

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Harris NL, Jaffe ES, Stein H et al. A revised European–American classification of lymphoid neoplasms: a proposal from International Lymphoma Study Group Blood 1994 84: 1361 1392

    CAS  Google Scholar 

  2. Trump DL, Mann RB . Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. A poor prognostic subset of patients with non-Hodgkin's lymphoma Cancer 1982 50: 277 282

    Article  CAS  Google Scholar 

  3. Lichtenstein AK, Levine A, Taylor CR et al. Primary mediastinal lymphoma in adults Am J Med 1980 68: 509 514

    Article  CAS  Google Scholar 

  4. Kirn D, Mauch M, Shaffer K et al. Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients J Clin Oncol 1993 11: 1336 1343

    Article  CAS  Google Scholar 

  5. Jacobson JO, Aisemberg AC, Lamarre L et al. Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy Cancer 1988 62: 1893 1898

    Article  CAS  Google Scholar 

  6. Lazzarino M, Orlandi E, Paulli M et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicentre study of 106 patients J Clin Oncol 1997 15: 1646 1653

    Article  CAS  Google Scholar 

  7. Todeschini G, Ambrosetti A, Meneghini V et al. Mediastinal large-B-cell-lymphoma with sclerosis: a clinical study of 21 patients J Clin Oncol 1990 8: 804 808

    Article  CAS  Google Scholar 

  8. Rohatiner AZS, Whelan JS, Ganjoo RK et al. Mediastinal large-cell lymphoma with sclerosis Br J Cancer 1994 69: 601 604

    Article  CAS  Google Scholar 

  9. Pettengell R, Radford JA, Morgenstern GR et al. Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin lymphoma J Clin Oncol 1996 14: 586 592

    Article  CAS  Google Scholar 

  10. Gianni AM, Bregni M, Siena S et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma New Engl J Med 1997 336: 1290 1297

    Article  CAS  Google Scholar 

  11. Santini G, Salvagno l, Leoni P et al. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group J Clin Oncol 1998 16: 2796 2802

    Article  CAS  Google Scholar 

  12. Popat U, Przepiorka D, Champlin R et al. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome J Clin Oncol 1998 16: 63 69

    Article  CAS  Google Scholar 

  13. Bouabdallah R, Coso D, Costello R et al. Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center Bone Marrow Transplant 2000 25: 35 40

    Article  CAS  Google Scholar 

  14. Sehn LH, Antin JH, Shulman LN et al. Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation Blood 1991 19: 717 723

    Google Scholar 

  15. The non-Hodgkin's lymphoma classification project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma Blood 1997 89: 3909 3918

  16. Haioun C, Lepage E, Gisselbrecht CH et al. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and non-Hodgkin's lymphoma in first complete remission: a study of 466 patients J Clin Oncol 1994 12: 2543 2551

    Article  CAS  Google Scholar 

  17. Haioun C, Lepage E, Gisselbrecht CH et al. Benefit of autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87–2 J Clin Oncol 1997 15: 1131 1137

    Article  CAS  Google Scholar 

  18. Carbone PP, Kaplan HS, Musshoff K et al. Report of the committee on Hodgkin's disease staging classifications Cancer Res 1971 31: 1860 1861

    CAS  Google Scholar 

  19. Nademanee A, Molina A, O'Donnel M et al. Results of high dose therapy and autologous bone marrow/stem cell transplantation in poor-risk intermediate and high grade lymphoma Blood 1997 90: 3844 3852

    CAS  Google Scholar 

  20. Martelli MP, Martelli M, Pescarmona E et al. MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis Ann Oncol 1998 9: 1027 1029

    Article  CAS  Google Scholar 

  21. O'Reilly SE, Hoskins P, Klimo P et al. MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease Ann Oncol 1991 2: 17 23

    Article  Google Scholar 

  22. Velasquez WS, Cabanillas F, Salvador P et al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethazone (DHAP) Blood 1988 71: 117 122

    CAS  Google Scholar 

  23. Mills W, Chopra R, McMillan A et al. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non Hodgkin Lymphoma J Clin Oncol 1995 13: 588 595

    Article  CAS  Google Scholar 

  24. Labopin M . EBMT: statistical guidelines EBMT News 1999 3: 4 5

    Google Scholar 

  25. Lazzarino M, Orlandi E, Paulli M et al. Primary mediastinal B cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features J Clin Oncol 1993 11: 2306 2313

    Article  CAS  Google Scholar 

  26. Bieri S, Ruggero E, Zucca E et al. Primary mediastinal large B-cell lymphoma: the need for prospective controlled clinical trials Leuk Lymphoma 1999 35: 537 544

    Article  CAS  Google Scholar 

  27. Philip T, Armitage JO, Spitzer G et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin lymphoma New Engl J Med 1987 316: 1493 1502

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Niguarda Ca’ Granda Hospital, Milano, Italy

    HR Cairoli, G Grillo, A Tedeschi, L Gargantini, P Marenco, E Tresoldi, L Barbarano, AM Nosari & E Morra

Authors
  1. HR Cairoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Grillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Tedeschi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L Gargantini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P Marenco
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E Tresoldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L Barbarano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. AM Nosari
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. E Morra
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cairoli, H., Grillo, G., Tedeschi, A. et al. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis. Bone Marrow Transplant 29, 473–477 (2002). https://doi.org/10.1038/sj.bmt.1703401

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703401

Keywords

This article is cited by

Search

Advanced search

Quick links